Evidence map›Paper›PMID 40463344›Full record

ArticleRSC advances2025

Rational design of a lead-free Cs

Dhiyaneshwari Balaji, G Swati

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dhiyaneshwari BalajiCentre for Nanotechnology Research, Vellore Institute of Technology Vellore 632014 Tamil Nadu India swati.g@vit.ac.in.
G SwatiCentre for Nanotechnology Research, Vellore Institute of Technology Vellore 632014 Tamil Nadu India swati.g@vit.ac.in.ORCID https://orcid.org/0000-0003-1133-8616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Compared with lead halide perovskites, double perovskites (DPs) have drawn much attention because of their intriguing optoelectronic qualities, environmental stability, and non-toxicity. Herein, we systematically designed a Cs

Identifiers

PMID40463344
PMCPMC12131808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.